- Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poo…
Number of the records: 1  

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial

  1. TitlePersonalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial / Fizazi K,, Mardiak J., Reckova, M. ... [et al.]
    Another responsib. Mardiak, Jozef (Bibliographic antecedent)
    Rečková, Mária (Bibliographic antecedent)
    Redakcia Onkológia (Adapter)
    NoteJ Clin Oncol., 2024 Aug 21:JCO2301960
    In Onkológia. -- ISSN 1336-8176. -- Roč. 19, č. 4 (2024), s. 317
    Call numberC 3069
    MeSH Subject nádory z germinatívnych a embryonálnych buniek
    progresia choroby
    protokoly kombinovanej protinádorovej chemoterapie
    Keywords režim terapeutický intenzifikovaný
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.